SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-15-012062
Filing Date
2015-08-13
Accepted
2015-08-13 08:28:26
Documents
2
Period of Report
2015-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1706
2 LIMITED POWER OF ATTORNEY limitedpowerofattorney.txt EX-24 4213
  Complete submission text file 0001179110-15-012062.txt   7329
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Al-Wakeel Yasir B. (Reporting) CIK: 0001650691 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35409 | Film No.: 151048791